Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Post by Ciaoon Feb 04, 2024 5:06pm
114 Views
Post# 35862101

How does the investment community view Gilles?

How does the investment community view Gilles?CEAPRO has a reputation for poor communication. An analyst appearing on BNN in 2019, Fabrice Taylor said of CEAPRO, “not public markets people” and that the company should be private (ref. https://www.bnnbloomberg.ca/video/fabrice-taylor-discusses-ceapro~1584602).
Another BNN guest analyst, Jason Del Vicario had a concern about communication as well with the comment “… didn’t like their weak disclosure” . Doesn't this sound familiar to us?

In the summer of 2022, a small microcap manager from Rivemont approached Gilles and JTC with respect to getting an update on the company, his calls were not returned. In my attempt to connect microcap managers to CEAPRO, I was made aware of this situation by coincidence. Despite me reaching out, the micro cap manager said he was no longer interested in CEAPRO as he said he got the impression that the company was not interested in exposure and not interested in developing a relationship. It is unfortunate as Rivemont (Montreal based) took part in a financing led by Echelon Partners in 2016 and Gilles said he was familiar with Rivemont.

Let's get a CEO who understands that being a public company you need to properly communicate with fund managers, analysts and retail investors. Imagine if fund managers took large positions in the company and held Gilles somewhat accountable for results.

OATS, you have an opportunity to change all this. Say NO to the sham merger, say NO to Gilles at the AGM and let's push for a new CEO who cares about shareholders.
<< Previous
Bullboard Posts
Next >>